Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
09/09/2008 | US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
09/09/2008 | US7423149 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders |
09/09/2008 | US7423147 Therapy of Histamine H3 receptor mediated diseases |
09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
09/09/2008 | CA2366205C Biphenyl derivatives |
09/04/2008 | WO2008106635A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors |
09/04/2008 | WO2008104595A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
09/04/2008 | WO2008104582A2 Novel method for producing teta by means of eddn |
09/04/2008 | US20080214612 for therapy of endometriosis and/or uterine leiomyoma/leiomyomata; 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine |
09/04/2008 | US20080214571 e.g. 1-(3-Phenylsulfonyl-phenyl)piperazine; serotonin receptor modulator; anxiolytic agent, antidepressant, cognition activator; schizophrenia, obesity, Alzheimer's disease |
09/04/2008 | US20080214570 Therapeutic Agents |
09/04/2008 | US20080214562 Chemical Compounds |
09/04/2008 | US20080214554 Methods for preventing or treating cardiac arrhythmia |
09/04/2008 | US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics |
09/04/2008 | US20080214541 Such as 2-(1-naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; differentiating cells into osteoblast lineage; osteoporosis |
09/04/2008 | CA2679489A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors |
09/04/2008 | CA2678043A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
09/03/2008 | EP1963296A2 Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates |
09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
09/03/2008 | EP1257541B1 Polypharmacophoric agents |
09/03/2008 | CN101258138A Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
09/03/2008 | CN101255152A Preparation method and use of piperazine having cytotoxic activity |
09/03/2008 | CN101255119A Novel tetrahydro curcumin derivatives and salt |
09/03/2008 | CN100415861C Soft compound and use thereof |
09/03/2008 | CN100415729C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
09/03/2008 | CN100415728C Alkylol piperazine derivative optical isomer or its salt and its application for preparing medicament |
09/02/2008 | US7420003 Compounds and a novel process for their preparation |
09/02/2008 | US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
09/02/2008 | US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes |
09/02/2008 | US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
09/02/2008 | CA2387999C Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
08/28/2008 | WO2008101914A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
08/28/2008 | US20080207701 Opioid receptor antagonists |
08/28/2008 | US20080207693 Mitotic Kinesin Inhibitors |
08/28/2008 | US20080207689 Formamide Derivatives For The Treatment of Diseases |
08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
08/28/2008 | US20080207633 Conjugated to polyoxyethylene glycol; analgesics; antidiabetic agents; anticancer agents; sleep disorders; antidepressants; anxiolytic agents |
08/28/2008 | US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects |
08/28/2008 | US20080207606 Immunology diseases; analgesics; antiarthritic agents; cardiovascular disorders; antiischemic agents; skin disorders;antiulcer agents; bone disorders; antihistamines |
08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
08/28/2008 | CA2675669A1 Novel compounds |
08/27/2008 | EP1961738A1 New compounds with antiglutamatergic properties and uses thereof |
08/27/2008 | EP1960395A1 Plasminogen activator inhibitor-1 inhibitors |
08/27/2008 | EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors |
08/27/2008 | EP1960343A2 Indene derivatives, their preparation and use as medicaments |
08/27/2008 | EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
08/27/2008 | EP1200390B1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides |
08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
08/27/2008 | CN100413854C Process for preparing trimetazidine and its medicinal salts |
08/27/2008 | CN100413848C Acylsulfamoyl benzoic acid amides, plant protection agents containing same, and method for producing same |
08/27/2008 | CN100413820C Nitroaromatic solubilizer for nitroxyls in aromatic solvents |
08/26/2008 | US7417045 Antiinflammatory agents;to treat chemokine mediated diseases; Antitumor agents; autoimmune diseases |
08/26/2008 | US7417043 3-substituted 4-(phenyl-N-alkyl)-piperazine derivatives; central nervous system disorders; dualistic dopaminergic action profile with antagonist-like effects on brain neurochemistry and mild agonist-like effects on normal behavior, induce inhibition of behavior in hyperactivity; oral bioavailability |
08/26/2008 | US7417022 Amino acid for deliverying active materials; bioavailability |
08/21/2008 | WO2008099286A2 Improved process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2- piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide |
08/21/2008 | WO2008098751A1 New compounds with antiglutamatergic properties and uses thereof |
08/21/2008 | WO2008075184A3 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them |
08/21/2008 | US20080200474 Novel flunarizine salt forms and methods of making and using the same |
08/21/2008 | US20080200471 central nervous system disorders; mood or cognitive disorder; gastrointestinal disorders; 4-methyl-7-[(6-piperazin-1-yl-1H-indol-1-yl)sulfonyl]-3,4-dihydro-2H-1,4-benzoxazine; 1-methyl-5-[(6-piperazin-1-yl-1H-indol-1-yl)sulfonyl]-1H-indole; 6-(6-Piperazin-1-yl-indole-1-sulfonyl)-4H-benzo[1,4]oxazin-3-one |
08/21/2008 | US20080200467 alpha keto amides and alpha hydroxy amides; N-[3-(3-Morpholin-4-yl-propoxy)-phenyl]-2-oxo-2-(4-trifluoromethyl-phenyl)-acetamide; N-Adamantan-1-yl-2-(3-benzyloxyphenyl)-2-hydroxy-acetamide; hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases |
08/21/2008 | US20080200466 Organic Compounds For the Treatment of Inflammatory or Allergic Conditions |
08/21/2008 | US20080200460 Chemical Compounds |
08/21/2008 | US20080200459 Tetrahydroquinoline cannabinoid receptor modulators |
08/21/2008 | US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine |
08/20/2008 | EP1957473A2 Process for preparing substituted aryl cycloalkanol derivatives |
08/20/2008 | EP1957472A1 Method for producing ionic liquids |
08/20/2008 | EP1957470A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
08/20/2008 | EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
08/20/2008 | EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
08/20/2008 | EP1285909B1 Process for the production of nitrogen compounds |
08/20/2008 | EP1249233B1 Npyy5 antagonists |
08/20/2008 | CN101248069A Androgen receptor modulators and method of treating disease using the same |
08/20/2008 | CN101248053A N-oxides as prodrugs of piperazine and piperidine derivatives |
08/20/2008 | CN101245039A Process for producing cis-4-(2-bromine vinyl)benzene sulfonamide(I) |
08/19/2008 | US7414076 Methods and compositions for treating amyloid-related diseases |
08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
08/19/2008 | US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
08/19/2008 | US7414041 Reducing tetracycline resistance in living cells |
08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
08/14/2008 | US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these |
08/14/2008 | US20080194551 Acetylene Derivatives |
08/14/2008 | US20080194536 Cyanoarylamines |
08/14/2008 | US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics |
08/13/2008 | EP1954678A1 Novel nk1 and nk2 antagonists |
08/13/2008 | EP1824837B1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
08/13/2008 | EP1581467A4 Ligands for metals and improved metal-catalyzed processes based thereon |
08/13/2008 | EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
08/13/2008 | EP0934924B1 Novel diamide compounds and drugs containing the same |
08/13/2008 | CN101243047A Phenoxy acetic acids as PPAR delta activators |
08/13/2008 | CN101239957A Method for synthesizing N-methylpiperazine |
08/13/2008 | CN101239928A Propanoic derivatives for treating lipid metabolism disorder |
08/13/2008 | CN100409939C Catalyst for synthesizing morphine through diethylene glycol ammoniation, and preparation method |
08/12/2008 | US7411092 Quaternary ammonium salts |
08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
08/12/2008 | US7411004 Sulphones which modulate the action of gamma secretase |
08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
08/12/2008 | US7410971 1,2-di(cyclic)substituted benzene compounds |